QA Addressing Drug Costs Reported on Prescription Drug Events (PDEs)

Please see the attached memo from Abby L. Block, Director, Center for Beneficiary Choices, that extends the deadline for Part D plans to request an opportunity to update their bids based on a misunderstanding of CMS's policy on reporting costs on PDEs. Thank you.